新冠药物临床试验的药物基因组学：为何现在它很重要？ - Suppr | 超能文献

Pharmacogenomics for Clinical Trials of COVID-19 Medicines: Why Is This Important Now?

作者信息

Şardaş Semra, Özdemir Vural

机构信息

Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istinye University, Istanbul, Turkey.

OMICS: A Journal of Integrative Biology, New Rochelle, New York, USA.

出版信息

OMICS. 2021 Nov;25(11):679-680. doi: 10.1089/omi.2021.0176. Epub 2021 Oct 25.

DOI:10.1089/omi.2021.0176

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Pharmacogenomics for Clinical Trials of COVID-19 Medicines: Why Is This Important Now?新冠药物临床试验的药物基因组学：为何现在它很重要？

OMICS. 2021 Nov;25(11):679-680. doi: 10.1089/omi.2021.0176. Epub 2021 Oct 25.

2

Re-purposed antiviral drugs without a purpose in COVID-19: a valuable lesson for clinicians.在新冠疫情中无明确用途而重新启用的抗病毒药物：给临床医生的宝贵教训

Eur Heart J. 2021 Mar 1;42(9):882-883. doi: 10.1093/eurheartj/ehab043.

3

Potential drug development and therapeutic approaches for clinical intervention in COVID-19.针对 COVID-19 的临床干预的潜在药物研发和治疗方法。

Bioorg Chem. 2021 Sep;114:105016. doi: 10.1016/j.bioorg.2021.105016. Epub 2021 May 25.

4

COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?新冠疫情：药物制剂与药物递送专家能提供什么？

Pharm Dev Technol. 2020 Jul;25(6):649. doi: 10.1080/10837450.2020.1764670.

5

Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak.重新定位和传统药物治疗 COVID-19 大流行的最新方法。

Mini Rev Med Chem. 2021;21(8):952-968. doi: 10.2174/1389557520666201124141103.

6

Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.小分子药物治疗 COVID-19 的发现：临床研究综述。

Mini Rev Med Chem. 2021;21(12):1431-1456. doi: 10.2174/1389557521666201228145755.

7

COVID-19 Pharmacotherapy: Drug Development, Repurposing of Drugs, and the Role of Pharmacogenomics.新型冠状病毒肺炎药物治疗：药物研发、药物再利用及药物基因组学的作用

Methods Mol Biol. 2022;2547:187-199. doi: 10.1007/978-1-0716-2573-6_8.

8

Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.重新定位药物以应对 COVID-19 大流行——一个洞察。

Curr Pharm Biotechnol. 2021;22(2):192-199. doi: 10.2174/1389201021999200820155927.

9

Drug researchers pursue new lines of attack against COVID-19.药物研究人员寻求对抗新冠病毒的新攻击路线。

Nat Biotechnol. 2020 Jun;38(6):659-662. doi: 10.1038/d41587-020-00013-z.

10

Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs.药物基因组学与 COVID-19：人类基因组与再利用药物相互作用的临床意义。

Pharmacogenomics J. 2021 Jun;21(3):275-284. doi: 10.1038/s41397-021-00209-9. Epub 2021 Feb 4.

引用本文的文献

1

Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.华法林药物基因组学在南非真实临床实践中的精准医学应用：利用 29 个药物基因中的 73 个变异体。

OMICS. 2022 Jan;26(1):35-50. doi: 10.1089/omi.2021.0199. Epub 2021 Dec 24.